Should You Get Off The Health Care & Biotech Express?

Friday's selling in Sector Select Health Care (XLV) and iShares Nasdaq Biotechnology (IBB) pushed them down over 1% for the day. Despite Friday's weakness the XLV is one of the top performing sector ETFs in 2015 as I noted in Friday's Week Ahead column. The IBB has had even a better year as it is up almost 20% and the year is not even half over. The fact that both ETFs had just challenged their all time highs makes a technician wonder if the short, intermediate or long term trend for these two m...